One & One Green Technologies stock soars 100% after IPO debut
BENTONVILLE, Ark. - Walmart (NYSE:WMT), the retail giant with over $693 billion in annual revenue and a market capitalization of $820 billion, announced Monday it has expanded its pharmacy delivery service to include refrigerated and reconstituted medications across the United States, becoming the first retailer to offer cold-chain prescriptions with groceries and everyday essentials in a single online order.
The expanded service now delivers temperature-sensitive medications such as insulin and GLP-1s, as well as reconstituted medications like pediatric amoxicillin, directly to customers’ doors. According to the company, refrigerated medications represent over 30% of Walmart Pharmacy sales. This expansion aligns with Walmart’s strong market position, as InvestingPro data shows the company maintaining robust revenue growth of 4.23% over the last twelve months.
"We continue to unlock new levels of convenience while also broadening access to critical medications," said Kevin Host, senior vice president of Pharmacy at Walmart, in a press release statement.
The company reports it has fulfilled over 4 million pharmacy delivery orders since launching the service less than a year ago. Walmart now delivers more than 90% of prescription medications through its service. According to InvestingPro analysis, 21 analysts have recently revised their earnings expectations upward for the upcoming period, suggesting strong confidence in the company’s growth initiatives. Discover 12 more exclusive ProTips and comprehensive financial analysis with an InvestingPro subscription.
To maintain medication quality during transport, Walmart uses insulated bags designed to maintain regulated temperatures and protect sensitive prescriptions from light exposure. Customers can track deliveries in real time through the Walmart app and must provide an electronic signature upon receipt.
Walmart+ members receive free pharmacy delivery as a membership benefit where available, while non-members pay a fee based on delivery preference. Customers can choose between Same-Day Scheduled, On-Demand, or Express delivery options.
The service integrates with insurance coverage, applying it automatically as it would for in-store purchases. Medications available through Walmart’s $4 generic Prescription Program are also eligible for delivery. With an overall financial health score rated as "GOOD" by InvestingPro, Walmart continues to demonstrate strong operational execution in its healthcare initiatives.
In other recent news, Walmart has been the focus of several notable developments. BofA Securities has raised its price target for Walmart to $125, maintaining a Buy rating after discussions with key executives, including CEO Doug McMillon and CFO John David Rainey. UBS also maintained its Buy rating with a $110 price target, following a visit to Walmart’s apparel pop-up in New York City, highlighting growth potential in the apparel sector. Bernstein reiterated an Outperform rating with a $117 target, citing potential earnings growth from e-commerce, retail media, and Indian investments.
Walmart is set to expand its global footprint by opening its first branded stores in South Africa by the end of 2025, incorporating local products and its "Every Day Low Prices" strategy. Additionally, CFO John David Rainey has adopted a new stock trading plan under Rule 10b5-1, allowing the sale of up to 40,000 shares in two tranches. These transactions are scheduled for early 2026 and will occur at market prices without Rainey’s direct control. These developments reflect Walmart’s strategic focus on growth and operational transparency.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.